Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 28;16(4):312-320.
doi: 10.14740/cr2086. eCollection 2025 Aug.

Increase in Aortic Valve Mean Gradients One Day After Transcatheter Aortic Valve Implantation: The Role of Mitral Regurgitation

Benjamin Fogelson  1   2 , Raj Baljepally  1 , Eric Heidel  3 , Steve Ferlita  1 , Travis Moodie  1 , Aladen Amro  1 , Stefan Weston  1
Affiliations

Increase in Aortic Valve Mean Gradients One Day After Transcatheter Aortic Valve Implantation: The Role of Mitral Regurgitation

Benjamin Fogelson et al. Cardiol Res. .

Abstract

Background: Following transcatheter aortic valve implantation (TAVI), transvalvular mean gradient is known to increase from immediate to 24 h post-procedure. While anesthesia, rapid-pacing, and volume status are blamed, the true etiology is unclear. To our knowledge, no prior studies have evaluated the effects of mitral regurgitation (MR) on the rise in post-TAVI transvalvular mean gradient.

Methods: A single-center, retrospective analysis of patients who underwent TAVI at our institution between 2011 to 2020 was performed (n = 378, males = 206). Patients were divided into two groups, no-to-mild MR (n = 327) and moderate-to-severe MR (n = 51) based on echocardiograms obtained prior to TAVI. Transvalvular gradients were compared between immediate and 24-h post-TAVI echocardiograms.

Results: The average age of no-to-mild MR patients (77 years (interquartile range (IQR): 71 - 84)) was similar to moderate-to-severe MR patients (79 years (IQR: 76 - 85), p=0.13). Both groups had similar procedural blood pressures and peri-procedural medication use. The change in 24-h post-TAVI mean transvalvular gradient was +6 mm Hg (IQR: 3.7 - 9) in the moderate-to-severe MR group and +6 mm Hg (IQR: 3.4 - 9) in the no-to-mild MR group (P = 0.87).

Conclusions: In this study, we evaluated the impact of preexisting MR on changes in transvalvular gradients following TAVI. We observed no statistically significant difference in 24-h post-TAVI gradient changes between patients with moderate-to-severe MR and those with no-to-mild MR. These findings suggest that baseline MR may not be a major determinant of early post-TAVI hemodynamics; however, further prospective studies are needed to confirm this observation.

Keywords: Mitral regurgitation; Transcatheter aortic valve implantation; Transvalvular gradient.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest regarding the content herein.

Figures

Figure 1
Figure 1
Change in transvalvular mean gradient across time for patients with no-to-mild MR and patients with moderate-to-severe MR. MR: mitral regurgitation; TAVI: transcatheter aortic valve implantation.
Figure 2
Figure 2
Change in transvalvular max gradient across time for patients with no-to-mild MR and patients with moderate-to-severe MR. MR: mitral regurgitation; TAVI: transcatheter aortic valve implantation.
See this image and copyright information in PMC

References

    1. Kronzon I, Jelnin V, Ruiz CE, Saric M, Williams MR, Kasel AM, Shivaraju A. et al. Optimal imaging for guiding TAVR: transesophageal or transthoracic echocardiography, or just fluoroscopy? JACC Cardiovasc Imaging. 2015;8(3):361–370. doi: 10.1016/j.jcmg.2015.01.003. - DOI - PubMed
    1. Saric M, Williams MR. Transthoracic echocardiography guidance for TAVR. JACC Cardiovasc Imaging. 2015;8(3):363–367. - PubMed
    1. Didier R, Benic C, Nasr B, Le Ven F, Hannachi S, Eltchaninoff H, Koifman E. et al. High post-procedural transvalvular gradient or delayed mean gradient increase after transcatheter aortic valve implantation: incidence, prognosis and associated variables. The FRANCE-2 Registry. J Clin Med. 2021;10(15):3221. doi: 10.3390/jcm10153221. - DOI - PMC - PubMed
    1. Khalili H, Pibarot P, Hahn RT, Elmariah S, Pilgrim T, Bavry AA, Maini B. et al. Transvalvular pressure gradients and all-cause mortality following TAVR: a multicenter echocardiographic and invasive registry. JACC Cardiovasc Interv. 2022;15(18):1837–1848. doi: 10.1016/j.jcin.2022.07.033. - DOI - PubMed
    1. Thyregod HGH, Ihlemann N. Measuring transvalvular aortic pressure gradients: answering questions or asking new ones? JACC Cardiovasc Interv. 2022;15(18):1849–1851. doi: 10.1016/j.jcin.2022.08.021. - DOI - PubMed

LinkOut - more resources